Evidence is mounting that something happens when youth start working that compels them to smoke. With this trend in mind, it's worth exploring potential strategies to prevent smoking among youth who enter the workforce.
This paper describes development of Positive Emotional and Sensory Expectancies of Smoking item banks that will serve to standardize the assessment of this construct among daily and nondaily cigarette smokers.
Smoking is a coping strategy for many smokers who then have difficulty finding new ways to cope with negative affect when they quit. This paper describes analyses conducted to develop and evaluate item banks for assessing the coping expectancies of smoking for daily and nondaily smokers.
The Patient-Reported Outcomes Measurement Information System (PROMIS®) Smoking Initiative has developed 6 item banks for assessing smoking behaviors and biopsychosocial correlates of smoking among daily and nondaily adult cigarette smokers.
At this point, asking the FDA to restrict marketing or to ban flavored products would be premature. The base of scientific evidence is growing, particularly with e-cigarettes, but it doesn't support additional regulatory action beyond what the FDA has already proposed.
Currently, evidence for the safety, harmfulness, utility, and addictiveness of e-cigarettes is lacking. The questions that research needs to answer, however, are clear as day—particularly since business is booming.
The present study examined smoking prevalence and the demographic, clinical and psychosocial characteristics associated with smoking among a sample of Veterans Affairs primary care patients with probable major depression.
CVS Caremark will stop selling cigarettes and other tobacco products at its CVS/pharmacy stores beginning Oct. 1. Though it stands to lose $2 billion dollars in annual revenue, CVS CEO Larry J. Merlo said that selling tobacco products is at odds with the company's mission of improving health outcomes.